Valine 50mg/5ml oral solution
Requires a prescription from a doctor or prescriber
Valine is a branched-chain essential amino acid that has stimulant activity.
Official documents, adverse reaction reporting, and safety monitoring
Report a side effect
Submit a Yellow Card report to the MHRA
Official medicine documents
Safety monitoring data
Yellow Card reports
The MHRA Yellow Card scheme collects reports of suspected side effects from healthcare professionals and patients. View the Drug Analysis Profile (iDAP) for real-world adverse reaction data.
View Drug Analysis Profile
Suspected adverse reactions reported for Valine
Browse all iDAP reports
Interactive Drug Analysis Profiles for all medicines
Report a side effect
Submit a Yellow Card report to the MHRA
Data from the MHRA Yellow Card scheme. A reported reaction does not necessarily mean the medicine caused it. Contains public sector information licensed under the Open Government Licence v3.0.
EudraVigilance
The European Medicines Agency (EMA) collects suspected adverse reaction reports from across the EU/EEA through the EudraVigilance system. Search for safety data on this medicine.
Search EudraVigilance database
Browse substances A–Z in the European adverse reaction database
About EudraVigilance
Learn about EU pharmacovigilance and safety monitoring
EudraVigilance data is published by the European Medicines Agency (EMA). A suspected adverse reaction is not necessarily caused by the medicine.
2 branded products available
Therapeutically similar medicines
Similarity is based on WHO Anatomical Therapeutic Chemical (ATC) classification and on a factual NHS dm+d therapeutic-grouping code prefix. Source data: NHS dm+d via TRUD (OGL v3.0), WHO ATC/DDD Index.
NHS prescribing volume and spending trends
Guidelines from the National Institute for Health and Care Excellence
NICE clinical guidance(14)
Mannitol dry powder for inhalation for treating cystic fibrosis (TA266)
Sinusitis (acute): antimicrobial prescribing (NG79)
Prontosan for treating acute and chronic wounds (HTG616)
The PLASMA system for transurethral resection and haemostasis of the prostate (HTG563)
Insertion of a double balloon catheter for induction of labour in pregnant women without previous caesarean section (HTG380)
The MIST Therapy system for the promotion of wound healing (HTG267)
DuraGraft for preserving vascular grafts (MIB184)
Complicated intra-abdominal infections: ceftolozane/tazobactam (ESNM75)
XprESS multi sinus dilation system for treating chronic sinusitis (HTG424)
Endometrial cryotherapy for menorrhagia (HTG101)
PLASMA system with button electrode for electrovaporisation of the prostate (MIB274)
Joint replacement (primary): hip, knee and shoulder (NG157)
Biodegradable spacer insertion to reduce rectal toxicity during radiotherapy for prostate cancer (HTG659)
Thermogard XP for therapeutic hypothermia after cardiac arrest (MIB37)
Source: National Institute for Health and Care Excellence (NICE). Contains public sector information licensed under the Open Government Licence v3.0.
Check stock at pharmacies and supply information
Pharmacy stock checkers
Search for this medicine at major UK pharmacy chains. These links open the retailer's own website — results depend on their current online catalogue.
Supply & safety information
Official UK regulator monitoring and safety alerts
Pharmacy links redirect to the retailer's own search and do not represent real-time stock levels. Shortage and safety information sourced from MHRA drug safety updates (gov.uk, Crown Copyright under OGL v3.0).
Codes for healthcare professionals and prescribing systems
These codes are used by healthcare IT systems and prescribers to identify this medicine.
NHS UK identifiers
SNOMED CT and dm+d codes from NHS TRUD (Technology Reference data Update Distribution), licensed under the Open Government Licence v3.0. BNF code shown is the factual mapping value distributed by NHS Business Services Authority (NHSBSA) in the dm+d supplementary file under OGL v3.0; it is not affiliated with, nor licensed from, the publishers of the British National Formulary.
Active and completed clinical studies from ClinicalTrials.gov
Source: ClinicalTrials.gov, a database of the U.S. National Library of Medicine (NLM), National Institutes of Health (NIH). Data accessed via ClinicalTrials.gov API v2. Trial information is provided for research purposes and does not constitute medical advice.
Academic studies and reviews for this medicine's active substance
Showing the 50 most relevant studies.
Reviews & meta-analyses: 3 · 1948–2023
Showing the 50 most relevant studies, sorted by most relevant.
Bernard Leclercq
Poultry science, 1998
- Animal Feed
- Lysine
- Threonine
Deyang Yu, Nicole E. Richardson, Cara L. Green, et al.
Cell Metabolism, 2021
- Diet
- Uncoupling Protein 1
- Mechanistic Target of Rapamycin Complex 1
Yasuaki Anami, Chisato M. Yamazaki, Wei Xiong, et al.
Nature Communications, 2018
- Antibodies, Monoclonal
- Antineoplastic Agents
- Breast Neoplasms
Magdalena Dorywalska, Russell G. Dushin, Ludivine Moine, et al.
Molecular Cancer Therapeutics, 2016
- Antibodies, Monoclonal
- Antineoplastic Agents
- Carbamates
Yuki Taya, Yasunori Ota, Adam C. Wilkinson, et al.
Science, 2016
- Cell Proliferation
- Cysteine
- Diet
T. Ray
Plant physiology, 1984
Jin Hwan Park, Kwang Ho Lee, Tae Yong Kim, et al.
Proceedings of the National Academy of Sciences, 2007
- Transcription, Genetic
- Escherichia coli
- Gene Amplification
Dario Neri, Thomas Szyperski, Gottfried Otting, et al.
Biochemistry, 1989
- Magnetic Resonance Spectroscopy
- Carbon Isotopes
- DNA-Binding Proteins
P. Zimniak, B. Nanduri, S. Pikula, et al.
European journal of biochemistry, 1994
- Base Sequence
- Chromatography, Affinity
- Enzyme Stability
V. Lubimov, E. Novikov, V.Z. Nozik, et al.
Physics Letters B, 1980
Sources: aggregated from Europe PMC (EMBL-EBI), OpenAlex, Crossref, PubMed and other open scholarly databases. Retracted articles are excluded. Study information is provided for research purposes and does not constitute medical advice.
Pharmacology and chemical data from DrugBank
Key facts
Drug status
Approved
Major interactions
None known
Half-life
Not available
Mechanism
(Applies to Valine, Leucine and Isoleucine) This group of essential amino acids…
Food interactions
None known
Human targets
3 targets
Data: DrugBank · CC BY-NC 4.0
Pharmacokinetics at a glance
Absorption
Metabolism
Pharmacokinetic data: DrugBank · CC BY-NC 4.0
How the body processes this drug — absorption, distribution, metabolism, and elimination
Proteins and enzymes this drug interacts with in the body
PMID:15890657 PMID:6765947
Propionyl-CoA carboxylase catalyzes the carboxylation of propionyl-CoA/propanoyl-CoA to D-methylmalonyl-CoA/(S)-methylmalonyl-CoA .
PMID:15890657 PMID:6765947
Within the holoenzyme, the alpha subunit catalyzes the ATP-dependent carboxylation of the biotin carried by the biotin carboxyl carrier (BCC) domain, while the beta subunit then transfers the carboxyl group from carboxylated biotin to propionyl-CoA (By similarity). Propionyl-CoA carboxylase also significantly acts on butyryl-CoA/butanoyl-CoA, which is converted to ethylmalonyl-CoA/(2S)-ethylmalonyl-CoA at a much lower rate .
PMID:6765947
Other alternative minor substrates include (2E)-butenoyl-CoA/crotonoyl-CoA (By similarity)
Enzymes involved in drug metabolism — important for understanding drug interactions
Proteins that transport this drug across cell membranes
PMID:11827462 PMID:18337592 PMID:28754537
Mediates both uptake and efflux of 3,5,3'-triiodothyronine (T3) and 3,5,3',5'-tetraiodothyronine (T4) with high affinity, suggesting a role in the homeostasis of thyroid hormone levels .
PMID:18337592
Responsible for low affinity bidirectional transport of the aromatic amino acids, such as phenylalanine, tyrosine, tryptophan and L-3,4-dihydroxyphenylalanine (L-dopa) .
PMID:11827462 PMID:28754537
Plays an important role in homeostasis of aromatic amino acids (By similarity)
Chemical identifiers
CAS, UNII, InChI Key and database cross-references
Show
Chemical identifiers
CAS, UNII, InChI Key and database cross-references
Linked compound data from DrugBank Open Data (CC BY-NC 4.0)
Valine
Additional database identifiers
Drugs Product Database (DPD)
939
Drugs Product Database (DPD)
9928
ChemSpider
6050
BindingDB
50463208
PDB
VAL
ZINC
ZINC000000895099
HUGO Gene Nomenclature Committee (HGNC)
HGNC:8654
GenAtlas
PCCB
GeneCards
PCCB
GenBank Gene Database
X73424
GenBank Protein Database
312812
UniProt Accession
PCCB_HUMAN
HUGO Gene Nomenclature Committee (HGNC)
HGNC:976
GenAtlas
BCAT1
GeneCards
BCAT1
GenBank Gene Database
U21551
GenBank Protein Database
1036780
Guide to Pharmacology
3210
UniProt Accession
BCAT1_HUMAN
HUGO Gene Nomenclature Committee (HGNC)
HGNC:12651
GenAtlas
VARS
GeneCards
VARS1
GenBank Gene Database
X59303
GenBank Protein Database
31545
UniProt Accession
SYVC_HUMAN
HUGO Gene Nomenclature Committee (HGNC)
HGNC:12651
GenAtlas
VARS
GeneCards
VARS1
GenBank Gene Database
X59303
GenBank Protein Database
31545
UniProt Accession
SYVC_HUMAN
HUGO Gene Nomenclature Committee (HGNC)
HGNC:8654
GenAtlas
PCCB
GeneCards
PCCB
GenBank Gene Database
X73424
GenBank Protein Database
312812
UniProt Accession
PCCB_HUMAN
HUGO Gene Nomenclature Committee (HGNC)
HGNC:976
GenAtlas
BCAT1
GeneCards
BCAT1
GenBank Gene Database
U21551
GenBank Protein Database
1036780
Guide to Pharmacology
3210
UniProt Accession
BCAT1_HUMAN
HUGO Gene Nomenclature Committee (HGNC)
HGNC:17027
GeneCards
SLC16A10
GenBank Gene Database
AB057445
GenBank Protein Database
18640047
UniProt Accession
MOT10_HUMAN
DrugBank citations
If you use DrugBank data in your research, please cite the following publications:
Show earlier publications
Structured knowledge from the free knowledge base
Linked open data from Wikidata (Q106345667), a free and open knowledge base operated by the Wikimedia Foundation. Data is available under the Creative Commons CC0 1.0 Public Domain Dedication.